The Research Nobody Interrogates: Why Ayurveda’s Scientific Culture Fails Before It Even Begins

An Ayurveda Unfiltered essay

The observations in this essay are personal, drawn from direct, long-term exposure to research methodology training, dissertation guidance, and editorial work — not from any official audit or institutional mandate. They are not intended to malign any individual scholar, guide, examiner, university, or institution. The pattern described here is systemic, and very nearly everyone inside this system, including the author, has operated within it at some point. The intent is to ask why the pattern persists, not to indict any one person for it.

Start with the title. Not the methodology, not the statistics, not the discussion section — the title. Because the title is where a piece of research first declares what it is: what population it studied, what intervention or exposure it examined, what it compared that to, what outcome it measured, and often, what design it used. A title is a discipline’s smallest unit of scientific accountability. If a field cannot get its titles right, it is very unlikely to be getting the substance right either — and the title is usually the first, easiest, cheapest thing to fix.

Over an extended period of reviewing published papers, PG synopsis titles, and even awarded PhD dissertation titles across Ayurveda institutions, one pattern stands out with uncomfortable consistency: a large majority of these titles do not follow any recognized scientific convention. They do not specify design. They do not specify population characteristics with any precision. They often promise a causal or comparative claim the study was never designed to support. Titles announce “A Study on the Effect of X in Y” without saying whether that study was a randomized trial, an observational cohort, a case series, or a compilation review — as if the design were an afterthought rather than the entire scientific identity of the work. This is not a stylistic quibble. A title that hides its own design is very often hiding the fact that the design was never properly decided in the first place.

Where the Rot Actually Starts

If the title problem were isolated, it would be a minor embarrassment. It isn’t isolated — it is the visible tip of a methodology problem that runs the length of the research pipeline.

Registered Protocols That Do Not Survive Scrutiny

A review of trial registry protocols filed for Ayurveda PG and PhD dissertations shows the same casualness at a deeper level. Assessment scales and grading systems are frequently assumed to be standardized instruments — validated, reliable, previously published — when in fact they are ad hoc, unvalidated, invented for the study itself, sometimes without a single sentence explaining their scoring logic or citing where the scale came from. Outcome measures are chosen without any visible justification for why that particular measure, at that particular time point, answers the stated research question. Sample size calculations, where present at all, often read as a number arrived at rather than a number derived. None of this is invisible — it sits in a publicly filed protocol, waiting for anyone with basic methodological training to notice. Very few do.

A Decade of Workshops, and Still the Same Papers

This is perhaps the most confounding part of the picture, because it isn’t a story of neglect — it is a story of enormous, visible, well-attended effort that somehow fails to move the needle. Research methodology and biostatistics workshops, seminars, and faculty development programmes have been running across the Ayurveda education system for well over a decade now. National-level conferences routinely carry a pre-conference or post-conference methodology workshop as a fixture of the programme. Faculty attend, complete the sessions, and proudly display the certificates of participation on their CVs, their college walls, their promotion files. And yet, year after year, the dissertations coming out of the same institutions, often guided by the same faculty who hold those very certificates, show no measurable improvement in design rigour, statistical planning, or reporting quality. Attendance has become the outcome. Nobody appears to be asking the far more important question: did this training actually change what gets produced? If a decade of structured capacity-building has not moved dissertation quality, the honest conclusion is not that more workshops are needed — it is that the workshop-to-practice pipeline itself is broken, and nobody is auditing that gap.

The Compilation Degree

Walk into most PG and PhD research centres in Ayurveda and a depressingly familiar template repeats itself: a compilation of pre-existing material, reorganized, re-titled, occasionally repackaged with a small clinical component attached almost as a formality. What is frequently missing is the thing a dissertation is supposed to demonstrate: a genuine research question, a rationale for why that question matters and hasn’t already been answered, an analysis that engages critically with the data rather than simply reporting it, a discussion that argues rather than restates, and some original intellectual contribution that did not exist in the literature before the scholar did the work. Without these elements, an MD, MS, or PhD stops being a certification of research capability and becomes, functionally, a credential required for appointment or promotion — a box to tick rather than a threshold to cross. And because everyone downstream knows this — the appointing college, the promoting authority, the next batch of scholars watching how the last batch got through — the incentive to actually do the harder version of the work keeps eroding, year after year, cohort after cohort.

Why Does Nobody Question It?

This is the question that matters more than any single flawed dissertation: why does a study with no defensible research question, an unvalidated outcome scale, and a title that doesn’t survive its own logic sail through synopsis approval, ethics clearance, progress review, and final viva — year after year, across nearly every PG and PhD centre — without being rejected, or even seriously challenged, for its scientific content?

A few uncomfortable possibilities are worth naming honestly, rather than politely avoided.

  • Guides are often not trained to the level the work requires, and are themselves products of the same compilation-degree pipeline — so the deficiency reproduces itself across generations rather than being corrected.
  • Examiners have every institutional incentive to pass a candidate and almost none to fail one — a rejection delays a batch, embarrasses a guide, and invites the same scrutiny back onto the examiner’s own department.
  • Ethics committees and synopsis review boards frequently check for procedural completeness — forms filled, signatures obtained — rather than for methodological soundness, because few members are equipped, or given the mandate, to do the latter.
  • There is no visible, public consequence for producing weak research. No dissertation gets retracted. No synopsis gets publicly flagged as sub-standard. No guide’s future applications get affected by a pattern of poor-quality output from their scholars. Without consequence, there is no selection pressure toward quality — only toward completion.
  • A quiet, unspoken solidarity operates across the system: today’s lenient examiner is tomorrow’s scholar seeking leniency in return. Rigour, in this arrangement, is a cost nobody wants to be the first to impose.

None of this requires bad faith on anyone’s part. Most guides, examiners, and reviewers are not indifferent to quality — they are operating inside a system that has never actually made quality a condition of passing. When nothing downstream depends on rigour, rigour becomes optional, no matter how many workshops precede it.

The Substandard Research Nobody Stops

This pattern becomes most visible in certain recurring categories of study that keep appearing across Ayurveda PG and PhD output — studies built on premises that would not survive basic methodological scrutiny in any serious biomedical review process, yet continue to be approved, conducted, and awarded degrees for, year after year. Cow-urine-based interventions are a frequently cited example: studies proceeding with weak or absent standardization of the substance being tested, no pharmacological characterization of what is actually being administered, outcome measures unrelated to any plausible, testable mechanism, and conclusions asserted with a confidence the data cannot support. The scientific problem here is not the classical source of the intervention — Ayurveda’s classical materia medica deserves serious investigation. The problem is that the investigation itself is not held to any recognizable standard, and the education system that produces and awards these dissertations does not appear troubled by that fact. If a compound cannot be standardized, an outcome cannot be justified, and a mechanism cannot be articulated even provisionally, the study should not clear synopsis review — not because of what it studies, but because of how it proposes to study it. That distinction — between subject matter and method — is precisely the distinction the system keeps failing to enforce.

The Monoculture of Clinical Studies

There is another pattern hiding inside the compilation-dissertation problem, and it deserves its own scrutiny because it distorts an entire discipline’s knowledge base, not just individual degrees: almost every PG and PhD department in Ayurveda, regardless of its actual subject matter, ends up producing a clinical trial. A Kayachikitsa department does a clinical study. A Panchakarma department does a clinical study. A Dravyaguna department, whose natural home is pharmacognosy and substance characterization, frequently ends up doing a clinical study on the substance rather than characterizing the substance itself. Even Samhita Siddhanta, whose subject is the foundational text and its interpretation, is regularly pulled toward a clinical arm to satisfy an unwritten expectation that every dissertation must end in patients and outcome scores, regardless of whether that is the right instrument to answer the question the department actually specializes in.

The clearest casualty of this pattern is Roga Nidana — the department whose entire classical mandate is diagnosis: disease definition, nosology, sign and symptom clusters, differential diagnosis, prognosis. This is precisely the department that should be producing India’s foundational diagnostic validation studies for Ayurveda — work establishing which classical signs actually cluster together in real patients, which nidana criteria have sensitivity and specificity worth publishing, which disease definitions hold up against modern diagnostic correlates and which do not. Instead, diagnostic validation studies from Roga Nidana departments are rare to the point of being a curiosity, and where they do exist, they are almost never built with the epidemiological and statistical rigour that diagnostic validation actually requires — no defined reference standard, no reported sensitivity or specificity, no inter-rater reliability testing for how consistently different examiners apply the same classical criteria, no receiver-operating-characteristic analysis, nothing that would let a diagnostic claim be trusted the way diagnostic claims are trusted in any other branch of medicine. A department built to answer “is this the correct diagnosis, and how do we know” ends up, more often than not, quietly running a clinical trial instead — because clinical trials are the template everyone already knows how to produce, supervise, and pass.

The consequence is a discipline that has spent decades generating an enormous volume of clinical-outcome data of questionable design, while leaving its own diagnostic and foundational infrastructure almost entirely unvalidated. It is difficult to responsibly measure whether a treatment works when the diagnostic category being treated has never itself been rigorously validated. Every clinical trial built on top of an unvalidated diagnosis is, in a very real sense, built on sand — however carefully its outcome measures are chosen.

Seven Decades In, and Still No Baseline

Postgraduate Ayurvedic education in its modern form is now well into its seventh decade. That is not a short runway. It is long enough that other health-science disciplines starting from comparable positions have, in the same span, built population-level reference data, standardized diagnostic criteria, and evidence-graded treatment guidelines. Ayurveda, across that same seven decades and thousands of completed dissertations, still does not have settled population parameters for Prakriti assessment — no widely validated, population-representative data on how Prakriti types actually distribute, cluster, or correlate with physiological or biochemical markers across different regions, ages, or demographic groups. It still does not have a rigorously validated, population-tested picture of how the signs and symptoms described in the Samhitas actually present in today’s patients, or how nidana criteria perform against modern diagnostic correlates. And, most tellingly for a system built on pharmacotherapy, it still does not have settled, widely accepted therapeutic efficacy and safety profiles for the majority of single herbs in routine use — dosage ranges, adverse-event profiles, drug interactions, pharmacokinetic basics — let alone for the vastly more common complex, multi-ingredient classical formulations that make up most of actual clinical practice.

This is the real cost of the compilation-dissertation and clinical-study monoculture problems described earlier: thousands of scholar-years and thousands of dissertations have been produced, and yet the field has not converged on the foundational, population-level answers that seven decades of sustained, well-designed research should have produced by now. Each new PG or PhD centre restarts, in effect, from the same unvalidated baseline as the ones before it, because nobody’s dissertation was designed to actually close that gap — it was designed to satisfy a template and produce a defensible degree.

And instead of confronting that gap directly, the discipline’s public conversation tends to retreat somewhere safer: back to the pre-Vedic period, to the antiquity and philosophical sophistication of the classical corpus, to a past-glory framing that is comfortable precisely because it asks nothing of the present. Antiquity is not evidence, and philosophical depth is not the same as an updated, population-tested evidence base. A living science is judged by whether its knowledge is being actively updated, tested, and revised against current data — not by how old or how elegant its founding texts were. A profession that keeps reaching backward for validation, rather than forward for data it still does not have, is choosing nostalgia over the harder, slower, more necessary work of building the baseline it should have built decades ago.

Where the Titles Fail Twice: Publication

The problem does not end at the dissertation stage. It repeats, almost identically, at the point of publication. A significant volume of what appears in Ayurveda journals carries titles that would not survive basic scrutiny at a methodologically serious publication: titles that promise causation from correlational or single-arm data, titles that omit design entirely, titles recycled in near-identical form across multiple papers from the same department with only the intervention swapped out, titles that oversell a finding the abstract itself cannot support. Peer review, where it exists at all, frequently checks formatting and completeness rather than the soundness of the question, the design, or the statistical approach. The result is a publication ecosystem where volume has become a proxy for productivity, and productivity has become disconnected from rigour.

This is precisely the gap that led to starting an independent journal from scratch — not as a business venture, but as a demonstration that a title-first, design-first, EQUATOR-guideline-compliant editorial standard is entirely achievable within Ayurveda publishing, without lowering submission volume to zero. Since then, a steady stream of enquiries has come in from scholars and faculty asking, specifically, how to structure a synopsis title correctly, how to phrase a research question so it matches the study design, how to write a methods section that would actually pass rigorous review. People clearly want to learn this. The demand is there. What is missing is not scholarly appetite — it is systemic will.

And that is the question this essay keeps circling back to: if one individual, working with limited resources, can build an editorial process that enforces basic scientific standards on titles, methods, and reporting, why can an entire education system — with universities, regulators, national conferences, and a decade of workshops behind it — not do the same at scale? The gap is not technical. Nobody is claiming EQUATOR guidelines, CONSORT, STROBE, or CARE are difficult to access or understand. The gap is that nobody with the authority to enforce these standards has been made accountable for whether they are actually followed.

The Common Thread

This essay’s argument is not that Ayurveda’s classical knowledge is weak, or that its practitioners are incapable of rigorous science. Quite the opposite — the fact that individual scholars, once shown a clear standard, adopt it quickly and ask for more guidance is evidence that capability was never the constraint. The constraint is that the system — guides, examiners, ethics committees, universities, journals, conference organizers — has never made methodological rigour a non-negotiable condition of approval, publication, or graduation. Workshops have been offered generously. Standards have not been enforced consistently. And in the absence of enforcement, even well-intentioned training becomes a certificate exercise rather than a quality mechanism.

Until synopsis committees are willing to send a title back for revision, until examiners are willing to fail a compilation dissertation on scientific grounds, until journals are willing to reject a paper because its title makes a claim its data cannot support, the volume of published output in Ayurveda will keep growing while its scientific credibility keeps eroding — quietly, unremarked, one uninterrogated title at a time.

Dr. Aakash Kembhavi

*MD (Ayu-Shalya), PGDMLS, MS (Counseling & Psychotherapy) Academician, Clinician & Researcher Chief Editor, International Journal of Ayurveda*

Share your thoughts in the comments below.